Aurinia Pharmaceuticals Inc (AUPH)
Financing Cash Flow
$5.04M
Quarterly · Period ending: · USD
AUPH Financing Cash Flow
Latest reported$5.04Mperiod ending
Latest reported$5.04Mperiod ending
AUPH Quarterly Cash from Financing ($1.26M → $5.04M)
Quarterly financing cash flow
High-resolution chart · PNG
AUPH financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 5,037,235 | |
| -53,685,000 | |
| -511,440 | |
| -10,490,000 | |
| -44,394,000 | |
| -49,337,000 | |
| -23,046,000 | |
| -2,722,000 | |
| -8,273,000 | |
| -15,051,000 | |
| -5,577,000 | |
| -2,332,000 | |
| 1,140,000 | |
| 1,639,000 | |
| 688,000 | |
| -23,872 | |
| 1,340,000 | |
| 405,000 | |
| 205,722,000 | |
| 9,082,000 | |
| 1,279,000 | |
| 5,029,000 | |
| 1,242,000 | |
| 189,257,000 | |
| 955,000 | |
| 2,922,000 | |
| 196,829,000 | |
| 14,851,000 | |
| 435,000 | |
| 31,651,000 | |
| 612,000 | |
| 8,000 | |
| 3,394,000 | |
| 0 | |
| 2,205,000 | |
| 1,243,000 | |
| -476,000 | |
| 172,180,000 | |
| 28,540,000 | |
| 7,435,000 | |
| 6,640,000 | |
| 0 | |
| 0 | |
| 56,000 | |
| 414,000 | |
| 369,000 | |
| 542,000 | |
| 477,000 | |
| 34,000 | |
| 46,837,000 | |
| -205,459 | |
| 5,563,310 | |
| 838,275 | |
| -7,863 | |
| 750,233 | |
| -11,176 | |
| -10,815 | |
| -11,025 | |
| 25,162 | |
| -161,208 | |
| 8,434 | |
| 2,409,688 | |
| 66,788 | |
| 4,560,340 | |
| 16,127 | |
| 0 | |
| -196,021 | |
| -754,276 | |
| 926,381 | |
| -9,587,392 | |
| -1,544,636 | |
| -636,860 | |
| 12,829,885 | |
| -325,464 | |
| -343,394 | |
| 2,024,500 | |
| 2,291,626 | |
| 32,058,772 | |
| -334,638 | |
| -411,730 | |
| -374,111 | |
| -151,827 | |
| 153,163 | |
| 15,468,532 | |
| -12,784 | |
| -348,020 | |
| 896,222 | |
| 4,009,772 | |
| -38,980 | |
| -1,525 | |
| 465,061 | |
| 13,919,765 | |
| 10,513,277 | |
| -280,015 | |
| 101,865 | |
| -604,623 | |
| 9,622,334 | |
| 3,256,003 | |
| 18,734,948 | |
| 1,772,553 |